Sirtuins: Common Targets in Aging and in Neurodegeneration

被引:0
|
作者
de Oliveira, Rita Machado [1 ]
Pais, Teresa F. [1 ]
Outeiro, Tiago Fleming [1 ,2 ]
机构
[1] Inst Mol Med, Cell & Mol Neurosci Unit, P-1649028 Lisbon, Portugal
[2] Fac Med Lisbon, Inst Fisiol, P-1649028 Lisbon, Portugal
关键词
Neurodegeneration; sirtuins; Parkinson's disease; Alzheimer's disease; therapeutic targets; aging; FOXO TRANSCRIPTION FACTORS; SMALL-MOLECULE ACTIVATORS; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; HISTONE DEACETYLASE; ALZHEIMERS-DISEASE; SIRT1; ACTIVATION; ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aging has been a subject of interest since primordial times. More recently, it became clear that aging is the major known risk factor for several neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. A major focus in the field of aging is to examine whether the genetic regulators of lifespan also regulate the trigger and/or progression of age-related disorders. Sirtuins, which belong to the Sir2 family of NAD(+)-dependent deacetylases, are known to regulate longevity in yeast, worms, and flies. In mammals, there are seven homologs of the yeast Sir2, Sirt1-7. Therefore, the challenge now is to unravel howthe seven mammalian Sir2 proteins communicate to regulate the cross talk between aging and the onset and progression of age-related disorders. Here, we review how sirtuins contribute for aging and, in particular, for neurodegeneration and how they are becoming attractive targets for therapeutic intervention.
引用
收藏
页码:1270 / 1280
页数:11
相关论文
共 50 条
  • [41] Sirtuins and Accelerated Aging in Scleroderma
    Anne E. Wyman
    Sergei P. Atamas
    Current Rheumatology Reports, 2018, 20
  • [42] Sirtuins as regulators of mammalian aging
    Naiman, Shoshana
    Kanfi, Yariv
    Cohen, Haim Y.
    AGING-US, 2012, 4 (08): : 521 - 522
  • [43] Sirtuins, aging, and cardiovascular risks
    Gaia Favero
    Lorenzo Franceschetti
    Luigi Fabrizio Rodella
    Rita Rezzani
    AGE, 2015, 37
  • [44] Sirtuins as potential targets for metabolic syndrome
    Guarente, Leonard
    NATURE, 2006, 444 (7121) : 868 - 874
  • [45] Sirtuins in Multiple Sclerosis: The crossroad of neurodegeneration, autoimmunity and metabolism
    Foolad, Forough
    Khodagholi, Fariba
    Javan, Mohammad
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 34 : 47 - 58
  • [46] Sirtuins as Possible Targets in Neurodegenerative Diseases
    Donmez, Gizem
    CURRENT DRUG TARGETS, 2013, 14 (06) : 644 - 647
  • [47] Sirtuins as potential targets for metabolic syndrome
    Leonard Guarente
    Nature, 2006, 444 : 868 - 874
  • [48] Sirtuins: Novel targets for metabolic disease
    Elliott, Peter J.
    Jirousek, Michael
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (04) : 371 - 378
  • [49] Serum biomarkers associated with aging and neurodegeneration in common marmosets (Callithrix jacchus)
    Phillips, Kimberley A.
    Lopez, Matthew
    Bartling-John, Evelyn
    Meredith, Reagan
    Buteau, Anna
    Alvarez, Addaline
    Ross, Corinna N.
    NEUROSCIENCE LETTERS, 2024, 819
  • [50] Sirtuins, Cell Senescence, and Vascular Aging
    Kida, Yujiro
    Goligorsky, Michael S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (05) : 634 - 641